Paracelsus Private Medical University, Salzburg (Austria)
Member of:
Dr. Alexander E. Berezin has received PhD in 1994 in the State Medical University of Zaporozhye (Ukraine). He is currently working as Senior Consultant, Lecturer and Professor of Medicine in the State Medical University of Zaporozhye (Ukraine). His research goals are fundamental study of biological markers, the development of cardiovascular prevention and rehabilitation. Based on this research and training in heart failure he has received several awards and honors. He has a regional and national profile. He has published 1050 papers and more in reputed journals, 57 books/chapters and has been serving as an editorial board member of repute.
Low levels of irisin predicted worsening kidney function in dapagliflozin-treated patients with chronic heart failure and concomitant type 2 diabetes mellitus
Predictors of worsening kidney function and their relation to SGLT2 inhibitor dapagliflozin administration in type 2 diabetes mellitus patients with chronic heart failure
Event:
ESC Preventive Cardiology 2024
Topic:
Biomarkers
Session:
Managing risk in the cardio-renal continuum